Bragar Eagel & Squire, P.C. is investigating Alignment Healthcare, Inc. on behalf of stockholders over potential securities law violations. The investigation follows a July 8, 2026 Modern Healthcare report that a former executive filed a whistleblower lawsuit alleging the company misclassified routine operating expenses as capital expenditures to artificially inflate adjusted EBITDA and report its first full year of positive adjusted EBITDA as a public company. Alignment's stock fell $4.02, or 16.7%, to close at $20.03 per share on July 8, 2026 after the news. The law firm encourages investors who suffered losses to contact partners Brandon Walker or Melissa Fortunato to discuss their legal rights.
Alignment Healthcare LLCWhistleblower lawsuit alleging accounting misclassification to inflate EBITDA, triggering investigation and stock drop.